Tissue Engineering Part B: Reviews Issues Tissue Engineering Part C: Methods Issues Submit a Paper Subscribe/Renew All Issues Reprints/ePrints Back to Top backAbout About Mary Ann Liebert, Inc. Newsroom Privacy Policy SDG Commitment What We Do Publications All Publications (A-Z) Browse By Sub...
Tissue Engineering Part A是一本细胞组织与工程方向的期刊,创刊于2008年,由Mary Ann Liebert Inc.出版。期刊现任主编分别是G.Mikos博士及John P.Fisher博士。期刊ISSN号:1937-3341;EISSN号:1937-335X。最新影响因子为4.080分。 官网链接:https://www.liebertpub.com/loi/tea 01 分类 Tissue Engineering Part A...
Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications that repair or regenerate portions or whole tissues. This multidisciplinary journal brings together the principles of engineering and life sciences in the creation of artificial tissues an...
Tissue Engineering Part A影响因子 学术期刊《Tissue Engineering Part A》是一本卓越的生物医学期刊，以修复或再生部分或整个组织的尖端研究和应用推动了该领域的发展。这本多学科期刊汇集了人工组织和再生医学领域的工程和生命科学原理。组织工程分为三个部分，为该领域领先专家的开创性科学研究和临床应用开发提供了一...
基础信息 Tissue Engineering Part A是一本细胞组织与工程方向的期刊,创刊于2008年,由Mary Ann Liebert Inc.出版。期刊现任主编分别是G. Mikos博士及John P. Fisher博士。期刊ISSN号:1937-3341;EISSN号:1937-…
TISSUE ENGINEERING PART A简介 Magazine introduction 英文简介 Tissue Engineering (Part A) is the authoritative peer-reviewed journal focusing on the fundamental and applied experimental aspects for the development of therapeutic strategies to repair or regenerate tissue and organ function. Part A ...
《Tissue Engineering Part A》(《组织工程 A 部分》)是一本由Mary Ann Liebert Inc.出版的Chemical Engineering-Bioengineering学术刊物,主要刊载Chemical Engineering-Bioengineering相关领域研究成果与实践,旨在打造一种学术水平高、可读性强、具有全球影响力的学术期刊。本刊已入选SCIE来源期刊。该刊创刊于2008年,出版周期...
TISSUE ENG PT A ISSN:1937-3341 E-ISSN:1937-335X 投稿咨询学术服务 基本信息 BASIC INFORMATION 审稿时间: 出版周期:Monthly 出版国家或地区:United States 创刊:2008 影响因子:3.5 是否预警:否 语言:English 是否OA开放访问:未开放 研究方向:Chemical Engineering - Bioengineering ...
Tissue Engineering Part A提供两种发表模式，传统发表需支付约人民币667元/页和6671元的彩印费用，开放获取模式需支付约28091元。文章类型包含Original Article、Letter to the Editor、Technical Note。研究内容侧重于修复或再生组织和器官功能，以发展治疗策略。综上所述，Tissue Engineering Part A是细胞...
Engineering of Biologically Active Living Heart Valve Leaflets Using Human Umbilical Cord–Derived Progenitor Cells Dörthe Schmidt, Anita Mol, Bernhard Odermatt, Stefan Neuenschwander, Christian Breymann, Matthias Gössi, Michele Genoni, Gregor Zund, and ...